OFIX - オ―ソフィックス・インタ―ナショナル (Orthofix Medical Inc. )

OFIXのニュース

   The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight  2022/05/05 17:00:00 Benzinga
New York, USA, May 05, 2022 (GLOBE NEWSWIRE) -- The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight The Orthopedic Trauma Devices market is expected to boost owing to the rising incidence of trauma and accident cases, the increasing prevalence of degenerative bone disorders, the increasing number of sports-related injuries, rising technological advancements pertaining to orthopedic trauma devices, and the rising number of new product launches, among others. According to the latest report published by DelveInsight, " Orthopedic Trauma Devices Market Insight Report ," the global Orthopedic Trauma Devices market is expected to witness significant growth owing to an increase in the prevalence of simple fractures and severe life-threatening injuries. Furthermore, the rising number of accidents or other fatal incidences, along with the rising number of trauma associated with road accidents, fall injuries, and the increasing prevalence pertaining to osteoarthritis and orthopedic sports injury, is also a major factor contributing to the growth of Orthopedic Trauma Devices market.
   Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022  2022/04/28 11:00:00 Business Wire
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the first quarter 2022 before market open on Friday, May 6, 2022. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day. Interested parties may access the
   Bone Growth Stimulators Market to Progress at a Substantial CAGR of 5.34% by 2026, as per DelveInsight''s Analysis  2022/04/12 17:00:00 Benzinga
Las Vagas, USA, April 12, 2022 (GLOBE NEWSWIRE) -- Bone Growth Stimulators Market to Progress at a Substantial CAGR of 5.34% by 2026, as per DelveInsight''s analysis The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators. DelveInsight''s Bone Growth Stimulators Market Insights and Forecast report provides the current and forecast Bone Growth Stimulators Market, upcoming innovations in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Bone Growth Stimulators Market. Some of the essential factors from the Bone Growth Stimulators Market report: As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth and occupy the largest share in the Bone Growth Stimulators market.
   Orthofix wins FDA clearance for TrueLok EVO to address bone issues  2022/03/16 15:28:10 Seeking Alpha
Medical device company, Orthofix Medical <>, announced on Monday that the U.S
   Orthofix Medical upgraded at Stifel on growth trajectory and margin expansion  2022/03/04 19:09:16 Seeking Alpha
The shares of medical device and biologics company, Orthofix Medical <>, has risen sharply after Stifel upgraded it to Buy from Hold, citing the prospects in growth and margins
   Bone Growth Stimulator Market worth $1.5 billion by 2026 - Leading Key Players are Orthofix Medical Inc. (US), DJO Finance LLC (US), Zimmer Biomet (US)  2021/08/18 09:56:21 OpenPR
According to the new market research report "Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) Global Forecasts to 2026", published
   Orthofix Medical''s (OFIX) CEO Jon Serbousek on Q2 2021 Results - Earnings Call Transcript  2021/08/08 19:12:06 Seeking Alpha
   Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook  2021/08/06 19:30:05 Business Insider Markets
Orthofix Medical Inc (NASDAQ: OFIX ) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.
   Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021  2021/07/28 20:30:00 Wallstreet:Online
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the second quarter 2021 before market open on Friday, August 6, 2021. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Companys
   Spine Devices Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Medtronic, Globus Medical, Stryker, Johnson & Johnson (Depuy Synthes), Orthofix Medical, NuVasive,  2021/07/23 00:54:19 Jumbo News
This report studies the Spine Devices Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Spine Devices market segmented by company, region, type []
   Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 83.2% in October  2020/11/17 16:34:48 Transcript Daily
Orthofix Medical Inc. (NASDAQ:OFIX) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totalling 431,500 shares, a growth of 83.2% from the October 15th total of 235,500 shares. Approximately 2.3% of the shares of the company are sold short. Based on […]
   Orthofix Medical Analyst Valuation and EPS Growth Stock market Insights & financial analysis  2020/10/26 17:25:00 Stock Market Daily
Orthofix Medical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Orthofix Medical (NASDAQ:OFIX) Cut to Hold at BidaskClub  2020/10/25 07:52:46 Zolmax News
Orthofix Medical (NASDAQ:OFIX) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday, BidAskClub reports. A number of other brokerages have also recently commented on OFIX. ValuEngine raised Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Thursday, July […]
   Orthofix Medical (NASDAQ:OFIX) Earns Hold Rating from Analysts at Stifel Nicolaus  2020/10/23 07:06:51 Stock Observer
Stifel Nicolaus initiated coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a report issued on Tuesday, Analyst Ratings Network reports. The brokerage issued a hold rating and a $39.00 price target on the medical device company’s stock. Several other brokerages have also recently issued reports on OFIX. ValuEngine upgraded shares of Orthofix Medical from a […]
   Orthofix Medical (NASDAQ:OFIX) Research Coverage Started at Stifel Nicolaus  2020/10/21 09:36:45 Transcript Daily
Stifel Nicolaus started coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a research note released on Tuesday morning, AR Network reports. The brokerage issued a hold rating and a $39.00 price objective on the medical device company’s stock. Several other research analysts have also recently issued reports on OFIX. ValuEngine raised shares of Orthofix Medical […]

calendar